File(s) under permanent embargo

A Randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET study).

journal contribution
posted on 2023-03-17, 05:05 authored by Ann Livingstone
A Randomised phase II study of carboplatin and bevacizumab in recurrent glioblastoma multiforme (CABARET study).

History

Journal

Neuro-Oncology

ISSN

1522-8517

Publisher

Oxford University Press (OUP)